R. Donald Harvey PharmD
@DrDonaldHarvey
Vice President, Clinical Research • Executive Director, WISC • Professor, Emory School of Medicine • Opinions mine • #ctsm #oncopharm
ID:2248948615
https://winshipcancer.emory.edu/bios/faculty/harvey-r-donald.html 16-12-2013 15:53:09
2,9K Tweet
1,7K Takipçi
858 Takip Edilen
Congrats to Christina Knippler as lead author, our team, Ganesh lab, collaborators, R. Donald Harvey PharmD, & Mala Shanmugam, PhD for developing alexidine analogs that inhibit cancer invasion by inducing mitochondrial stress- support from Winship Cancer Institute of Emory University and National Cancer Institute. cell.com/iscience/fullt…
It's #WorldHealthDay 🌍 Revisit this #OpenAccess commentary by R. Donald Harvey PharmD et al calling for a concerted commitment to transform #ClinicalTrials and enable people with cancer to participate in clinical trials closer to home.
acsjournals.onlinelibrary.wiley.com/doi/full/10.10…
OncoAlert
#AACR24
What a fun morning with good friends R. Donald Harvey PharmD and James Davis, PharmD, BCOP!
#oncopharm #HOPA2024
Grateful for the chance to talk about this about this paper in Journal of Clinical Oncology with strategies to degender oncology to improve care for everyone. Thanks to Shannon Westin, MD, MPH, FASCO for the terrific podcast interview and work in gynonc. Transgender Cancer Patient Project Jennifer Griggs, MD, MPH, Professor R. Donald Harvey PharmD Juno Obedin-Maliver
A trial for every patient, a patient for every trial.
Our rural patients deserve equal opportunity.
1. FDA Form 1572 clarity
2. Local lab and radiology data
3. Expansive partnerships
#ctsm
ASCO
Winship Cancer Institute of Emory University
National Cancer Institute
#Oncology trials submitted for regulatory review are becoming increasingly complex. In The Lancet Oncology, we call on the #drugdevelopment community to find ways to make trials simpler. Donna Rivera Harpreet Singh, MD Paul Kluetz
thelancet.com/journals/lanon…
Today, we held a retirement party for this wonderful woman. Gayle is the first person patients on phase I trials Winship Cancer Institute of Emory University see, and she is never (and I mean never) without a kind word and a smile.
Thank you, Gayle, from everyone you've touched.
Winship hematologist Ajay Nooka, MD, MPH, has been named associate director for clinical research, providing strategic oversight for all Winship clinical research with a focus on supporting high-quality, safe and ethical research with equitable access. winshipcancer.emory.edu/about-us/newsr…
Wonderful lineup with new tools to consider how to make anticancer combinations more expeditiously available to patients Winship Cancer Institute of Emory University and everywhere #oncopharm
Please sign on - superb multidisciplinary and multi focused panels and plans for in-depth discussion and solutions of the promise and challenges of phase IB trial design and dose derivation #oncopharm Winship Cancer Institute of Emory University
🧠 Bortezomib-induced peripheral neuropathy was higher in Black pts (46% vs 34%, OR, 1.64; P = .047) w #MultipleMyeloma . Additional prevention strategies, close monitoring & appropriate supp. care measures are warranted. ➡️ fal.cn/3zXca R. Donald Harvey PharmD #SuppOnc #mmsm
A pre-clinical study reported in Molecular Therapy and led by Winship researchers has uncovered a simplified, economical manufacturing process for generating more potent #CARTcell therapies to treat solid tumors. Chrystal Paulos Gregory Lesinski #immunotherapy ➡️ fal.cn/3yR5d.
